NASDAQ · RCEL
Avita Medical Inc.
$16.71+$0.21 (+1.27%)
Avita Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
Loading market information…
ASX · SOM.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 04:21 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
SomnoMed Limited’s quoted price sits in the lower half of its reported 52-week range, 69.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
SomnoMed Limited’s next earnings report is currently expected on Feb 26, 2027, with estimated earnings per share of A$0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SomnoMed Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| A$46.50M0.0% vs estimate |
| Q2 2024 | Feb 27, 2024 | -A$0.05-239.41% vs estimate | A$45.10M+2.5% vs estimate |
|---|
| Q4 2023 | Aug 30, 2023 | -A$0.03-124.86% vs estimate | A$43.70M-1.8% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$16.71+$0.21 (+1.27%)
Avita Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
A$5.50+A$0.15 (+2.8%)
Tetratherix Ltd.’s quoted price sits in the upper half of its reported 52-week range, 31.93% below the high.
NZ$0.24NZ$0.00 (0.0%)
Pacific Edge Limited’s quoted price sits in the lower half of its reported 52-week range, 30.88% below the high.
A$0.55+A$0.02 (+2.8%)
Aroa Biosurgery Limited’s quoted price sits in the lower half of its reported 52-week range, 31.25% below the high.
$0.15$0.00 (0.0%)
Oneview Healthcare PLC’s quoted price sits in the lower half of its reported 52-week range, 6.25% below the high.
A$1.50+A$0.00 (+0.17%)
EMVision Medical Devices Ltd’s quoted price sits in the lower half of its reported 52-week range, 23.34% below the high.
A$0.46-A$0.03 (-6.12%)
Nyrada Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.06% below the high.
A$0.28A$0.00 (0.0%)
Austco Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 37.08% below the high.
